Summary
TherVacB aims to develop a therapeutic vaccine to cure patients living with chronic hepatitis B (CHB). More than 3% of the world's population are chronically infected with the hepatitis B virus (HBV). Worldwide 880,000 humans die each year from the sequelae. To enable such...
More information & hyperlinks
Web resources: | https://www.thervacb.eu |